1. Home
  2. TANH vs TCRT Comparison

TANH vs TCRT Comparison

Compare TANH & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$0.80

Market Cap

6.2M

Sector

N/A

ML Signal

HOLD

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$3.36

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
TCRT
Founded
2001
1998
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.7M
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
TANH
TCRT
Price
$0.80
$3.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.6K
11.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,900,000.00
Revenue This Year
N/A
$5,680,500.00
Revenue Next Year
N/A
N/A
P/E Ratio
$0.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.31
52 Week High
$3.13
$5.48

Technical Indicators

Market Signals
Indicator
TANH
TCRT
Relative Strength Index (RSI) 39.09 69.16
Support Level $0.76 $2.45
Resistance Level $1.03 $3.76
Average True Range (ATR) 0.09 0.21
MACD -0.01 0.10
Stochastic Oscillator 27.23 96.63

Price Performance

Historical Comparison
TANH
TCRT

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Share on Social Networks: